Valuation: Novartis AG

Market Cap 305B 278B 256B 232B 437B 28,681B 452B 3,083B 1,222B 15,391B 1,146B 1,122B 48,753B P/E 2026 *
24.4x
P/E 2027 * 19.1x
Enterprise Value 339B 308B 285B 257B 485B 31,831B 502B 3,422B 1,356B 17,082B 1,272B 1,245B 54,108B EV / Sales 2026 *
5.87x
EV / Sales 2027 * 5.41x
Free-Float
91.66%
Yield 2026 *
2.7%
Yield 2027 * 2.84%
1 day+1.27%
1 week+2.01%
Current month+1.48%
1 month+7.83%
3 months+10.88%
6 months+16.35%
Current year+23.87%
1 week 132.48
Extreme 132.48
137
1 month 123.64
Extreme 123.64
137
Current year 107.68
Extreme 107.68
137
1 year 99.45
Extreme 99.45
137
3 years 81.1
Extreme 81.1
137
5 years 72.84
Extreme 72.84
137
10 years 65.09
Extreme 65.09
137
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%+2.01%+30.01%+62.35% 302B
-0.82%+5.74%+39.64%+143.26% 1,286B
-1.12%+2.29%+44.21%+89.89% 688B
-0.16%+1.11%+26.76%+114.06% 521B
+1.14%+4.87%+43.06%+71.97% 386B
-2.23%-1.55%+55.47%+42.54% 364B
+0.37%+0.75%+3.71%+39.09% 287B
-0.72%+0.41%+37.29%+69.33% 252B
-0.30%+0.41%+34.04%+123.32% 208B
+2.44%+5.86%-8.29%-57.68% 181B
Average +0.52%+2.20%+30.59%+69.81% 448B
Weighted average by Cap. +0.07%+3.26%+35.14%+91.95%

Financials

2026 *2027 *
Net sales 57.75B 52.47B 48.48B 43.79B 82.64B 5,423B 85.55B 583B 231B 2,910B 217B 212B 9,218B 61.7B 56.05B 51.79B 46.78B 88.28B 5,793B 91.39B 623B 247B 3,109B 232B 227B 9,848B
Net income 12.75B 11.58B 10.7B 9.67B 18.24B 1,197B 18.88B 129B 50.99B 642B 47.83B 46.82B 2,035B 15.68B 14.25B 13.16B 11.89B 22.44B 1,473B 23.23B 158B 62.73B 790B 58.85B 57.6B 2,503B
Net Debt 33.55B 30.48B 28.17B 25.44B 48.01B 3,151B 49.7B 339B 134B 1,691B 126B 123B 5,356B 28.34B 25.75B 23.79B 21.49B 40.56B 2,661B 41.98B 286B 113B 1,428B 106B 104B 4,524B
Projected Income Statement - Annual - Novartis AG
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
16/11/26 CHF 135.76 +1.27% 1,875,146
13/11/26 CHF 134.06 -0.12% 3,376,655
12/11/26 CHF 134.22 +1.11% 2,714,722
11/11/26 CHF 132.74 -1.29% 3,528,282
10/11/26 CHF 134.48 +0.76% 2,544,288
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Novartis AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
161.73USD
Average target price
153.93USD
Spread / Average Target
-4.82%
  1. Stock Market
  2. Stocks
  3. NOVN Stock